- Home
- RYI vs ORIC Comparison
RYI vs ORIC Comparison
Compare RYI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- ORIC
- Stock Information
- Founded
- RYI 1842
- ORIC 2014
- Country
- RYI United States
- ORIC United States
- Employees
- RYI N/A
- ORIC N/A
- Industry
- RYI Metal Fabrications
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- RYI Industrials
- ORIC Health Care
- Exchange
- RYI Nasdaq
- ORIC Nasdaq
- Market Cap
- RYI 661.1M
- ORIC 633.7M
- IPO Year
- RYI N/A
- ORIC 2020
- Fundamental
- Price
- RYI $20.27
- ORIC $10.25
- Analyst Decision
- RYI Hold
- ORIC Strong Buy
- Analyst Count
- RYI 1
- ORIC 9
- Target Price
- RYI $28.00
- ORIC $18.75
- AVG Volume (30 Days)
- RYI 249.3K
- ORIC 572.3K
- Earning Date
- RYI 02-19-2025
- ORIC 03-10-2025
- Dividend Yield
- RYI 3.73%
- ORIC N/A
- EPS Growth
- RYI N/A
- ORIC N/A
- EPS
- RYI 0.64
- ORIC N/A
- Revenue
- RYI $4,703,700,000.00
- ORIC N/A
- Revenue This Year
- RYI N/A
- ORIC N/A
- Revenue Next Year
- RYI $1.76
- ORIC N/A
- P/E Ratio
- RYI $31.65
- ORIC N/A
- Revenue Growth
- RYI N/A
- ORIC N/A
- 52 Week Low
- RYI $17.18
- ORIC $6.33
- 52 Week High
- RYI $36.15
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- RYI 51.88
- ORIC 56.26
- Support Level
- RYI $20.04
- ORIC $9.39
- Resistance Level
- RYI $21.15
- ORIC $11.15
- Average True Range (ATR)
- RYI 0.73
- ORIC 0.74
- MACD
- RYI 0.40
- ORIC 0.16
- Stochastic Oscillator
- RYI 82.98
- ORIC 60.49
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.